Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves

American Journal of Veterinary Research

Volumn 65, Issue 3, 2004, Pages 363-372

  Woolums, Amelia R ^a   Brown, Corrie C ^a   Brown Jr , James C ^a,b   Cole, Dana J ^a   Scott, Melissa A ^a,c   Williams, Shamita M ^a   Miao, Congrong ^a,d  

^a UNIVERSITY OF GEORGIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c U S DEPARTMENT OF AGRICULTURE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ARTICLE; BREATHING RATE; CATTLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; IMMUNOHISTOCHEMISTRY; MEDIASTINUM LYMPH NODE; NONHUMAN; RECTUM TEMPERATURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS RESISTANCE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CATTLE; CATTLE DISEASES; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; T-LYMPHOCYTES;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 1542515292     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.363     Document Type: Article

References (31)

1. Baker JC, Werdin RE, Ames TR, et al. Study on the etiologic role of bovine respiratory syncytial virus in pneumonia of dairy calves. J Am Vet Med Assoc 1986;189:66-70.
2. Bryson DG, McFerran JB, Ball HJ, et al. Observations on outbreaks of respiratory disease in housed calves - (1) epidemiological, clinical and microbiological findings. Vet Rec 1978;103:485-489.
3. Martin SW, Bateman KG, Shewen PE, et al. The frequency, distribution and effects of antibodies, to seven putative respiratory pathogens, on respiratory disease and weight gain in feedlot calves in Ontario. Can J Vet Res 1989;53:355-362.
4. Pirie HM, Petrie L, Pringle CR, et al. Acute fatal pneumonia in calves due to respiratory syncytial virus. Vet Rec 1981;108:411-416.
5. Harrison LR, Pursell AR. An epizootic of respiratory syncytial virus infection in a dairy herd. J Am Vet Med Assoc 1985;187:710-720.
6. Baker JC, Rust SR, Ciszewski DK, et al. A safety trial of a bovine respiratory syncytial virus vaccine in feedlot calves. Bovine Pract 1986;21:70-72.
7. Larsen LE, Tegtmeier C, Pedersen E. Bovine respiratory syncytial virus (BRSV) pneumonia in beef calf herds despite vaccination. Acta Vet Scand 2001;42:113-121.
8. Kimman TG, Sol J, Westenbrink F, et al. A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Vet Q 1989;11:250-253.
9. Schreiber P, Matheise JP, Dessy F, et al. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian White Blue calves previously vaccinated with an inactivated BRSV vaccine. J Vet Med B Infect Dis Vet Public Health 2000;47:535-550.
10. Gershwin Q, Schelegle ES, Gunther RA, et al. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 1998;16:1225-1236.
11. Woolums AR, Singer RS, Boyle GA, et al. Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV. Vaccine 1999;17:1293-1297.
12. West K, Petrie L, Konoby C, et al. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves. Vaccine 2000;18:907-919.
13. Ellis J, West K, Konoby C, et al. Efficacy of an inactivated respiratory syncytial virus vaccine in calves. J Am Vet Med Assoc 2001;218:1973-1980.
14. Kucera CJ, White RG, Beckenhauer WH. Evaluation of the safety and efficacy of an intranasal vaccine containing a temperature-sensitive strain of infectious bovine rhinotracheitis virus. Am J Vet Res 1978;39:607-610.
15. Bryson DG, Adair BM, McNulty MS, et al. Studies on the efficacy of intranasal vaccination for the prevention of experimentally induced parainfluenza type 3 virus pneumonia in calves. Vet Rec 1999; 145:33-39.
16. Wright PF, Karron RA, Belshe RB, et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis 2000;182:1331-1342.
17. Gonzalez IM, Karron RA, Eichelberger M, et al. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults. Vaccine 2000;18:1763-1772.
18. Kimman TG, Westenbrink F, Straver PJ. Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and matternal antibodies. Vet Immunol Immunopathol 1989; 22:145-160.
19. Schultz R. Vaccines I would not use in my cattle, in Proceedings. 31st Annu Conv Am Assoc Bovine Pract 1998;31:119-120.
20. Woolums AR, Anderson ML, Gunther RA, et al. Evaluation of severe disease induced by aerosol inoculation of calves with bovine respiratory syncytial virus. Am J Vet Res 1999;60:473-480.
21. Collie DD. Pulmonary function changes and clinical findings associated with chronic respiratory disease in calves. Br Vet J 1992;148:33-40.
22. Taylor G, Thomas LH, Wyld SG, et al. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J Virol 1995;69:6658-6664.
23. Kelley LC, Mahaffey EA, Bounous DI, et al. Detection of equine and bovine T- and B-lymphocytes in formalin-fixed paraffin-embedded tissues. Vet Immunol Immunopathol 1997;57:187-200.
24. Woolums AR, Siger L, Johnson S, et al. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production. Vaccine 2003;21:1158-1164.
25. Manesse M, Delverdier M, Abella-Bourges N, et al. An immunohistochemical study of bovine palatine and pharyngeal tonsils at 21, 60 and 300 days of age. Anat Histol Embryol 1998; 27:179-185.
26. Rebelatto MC, Mead C, HogenEsch H. Lymphocyte populations and adhesion molecule expression in bovine tonsils. Vet Immunol Immunopathol 2000;73:15-29.
27. Schuh JC, Oliphant LW. Development and immunophenotyping of the pharyngeal tonsil (adenoid) in cattle. J Comp Pathol 1992; 106:229-241.
28. Velinova M, Thielen C, Melot F, et al. New histochemical and ultrastructural observations on normal bovine tonsils. Vet Rec 2001; 149:613-617.
29. Brandtzaeg P. Immune functions of human nasal mucosa and tonsils in health and disease. In: Bienenstock J, ed. Immunology of the lung and upper respiratory tract. New York: McGraw-Hill Book Co, 1984;28-95.
30. Brandtzaeg P, Baekkevold ES, Farstad IN, et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999;20:141-151.
31. Perry M, Whyte A. Immunology of the tonsils. Immunol Today 1998;19:414-421.